Henry Schein, Inc. (NASDAQ:HSIC) Receives $77.10 Consensus PT from Analysts

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have received an average rating of “Moderate Buy” from the twelve brokerages that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, five have given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among analysts that have covered the stock in the last year is $77.10.

Several brokerages recently commented on HSIC. UBS Group dropped their target price on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. Barrington Research cut their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Robert W. Baird lowered their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. Piper Sandler reiterated an “overweight” rating and issued a $86.00 price target on shares of Henry Schein in a research report on Friday, June 21st. Finally, Evercore ISI reduced their price objective on shares of Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a research report on Wednesday, August 7th.

Insider Buying and Selling

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.14% of the company’s stock.

Institutional Trading of Henry Schein

Hedge funds have recently made changes to their positions in the stock. KBC Group NV increased its stake in Henry Schein by 163.5% in the 4th quarter. KBC Group NV now owns 521,964 shares of the company’s stock valued at $39,518,000 after buying an additional 323,901 shares during the period. Everett Harris & Co. CA increased its stake in shares of Henry Schein by 13.9% in the first quarter. Everett Harris & Co. CA now owns 119,257 shares of the company’s stock worth $9,006,000 after acquiring an additional 14,580 shares during the last quarter. UniSuper Management Pty Ltd raised its holdings in shares of Henry Schein by 611.8% during the first quarter. UniSuper Management Pty Ltd now owns 13,695 shares of the company’s stock worth $1,034,000 after acquiring an additional 11,771 shares in the last quarter. Envestnet Portfolio Solutions Inc. grew its stake in Henry Schein by 64.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company’s stock valued at $3,138,000 after purchasing an additional 16,241 shares in the last quarter. Finally, Pzena Investment Management LLC grew its stake in Henry Schein by 61.4% in the fourth quarter. Pzena Investment Management LLC now owns 809,558 shares of the company’s stock valued at $61,292,000 after purchasing an additional 307,934 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Up 3.2 %

Shares of Henry Schein stock opened at $70.38 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. Henry Schein has a 1-year low of $60.01 and a 1-year high of $82.63. The business’s fifty day moving average price is $69.21 and its two-hundred day moving average price is $70.57. The company has a market capitalization of $8.92 billion, a P/E ratio of 23.78, a PEG ratio of 1.88 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.27 billion. During the same quarter in the prior year, the firm posted $1.31 EPS. Henry Schein’s revenue was up .0% compared to the same quarter last year. As a group, research analysts forecast that Henry Schein will post 4.75 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.